AirSculpt Technologies (AIRS) Aktienübersicht
AirSculpt Technologies, Inc. konzentriert sich zusammen mit seinen Tochtergesellschaften auf die Tätigkeit als Holdinggesellschaft für EBS Intermediate Parent LLC, die in den Vereinigten Staaten und Kanada Dienstleistungen im Bereich Körperkonturierung anbietet. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 0/6 |
| Künftiges Wachstum | 0/6 |
| Vergangene Leistung | 0/6 |
| Finanzielle Gesundheit | 3/6 |
| Dividenden | 0/6 |
AIRS Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
AirSculpt Technologies, Inc. Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | US$4.81 |
| 52-Wochen-Hoch | US$12.00 |
| 52-Wochen-Tief | US$1.51 |
| Beta | 2.37 |
| 1 Monat Veränderung | 9.07% |
| 3 Monate Veränderung | 44.88% |
| 1 Jahr Veränderung | -18.68% |
| 3 Jahre Veränderung | -45.03% |
| 5 Jahre Veränderung | n/a |
| Veränderung seit IPO | -69.73% |
Aktuelle Nachrichten und Updates
Narrative-Update • Jul 22
AIRS: Higher Fair Value And 2026 Guidance Will Support Bullish Repricing
Analysts have raised their fair value estimate for AirSculpt Technologies to $6.25 from $4.50, reflecting updated views on its long term P/E assumption and profitability metrics, while keeping revenue growth and discount rate expectations broadly consistent. What’s in the News for AirSculpt Technologies AirSculpt Technologies affirmed earnings guidance for the full year 2026, indicating an expected revenue range of approximately $151 million to $157 million.
Neues Narrative • Jul 21
Long-Term GLP-1 Tailwinds And New Procedures Will Transform Future Earnings Potential
Catalysts About AirSculpt Technologies AirSculpt Technologies operates centers that provide minimally invasive body contouring, skin tightening and related aesthetic procedures. What are the underlying business or industry changes driving this perspective?Narrative-Update • Jun 26
AIRS: Raised Price View And 2026 Outlook Will Shape Fair Risk Balance
Analysts have raised their price target on AirSculpt Technologies stock from $3.00 to $4.50, citing updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What’s in the News for AirSculpt Technologies AirSculpt Technologies affirmed revenue guidance for the full year 2026, with expectations of approximately US$151 million to US$157 million.Recent updates
Narrative-Update • Jul 22
AIRS: Higher Fair Value And 2026 Guidance Will Support Bullish Repricing
Analysts have raised their fair value estimate for AirSculpt Technologies to $6.25 from $4.50, reflecting updated views on its long term P/E assumption and profitability metrics, while keeping revenue growth and discount rate expectations broadly consistent. What’s in the News for AirSculpt Technologies AirSculpt Technologies affirmed earnings guidance for the full year 2026, indicating an expected revenue range of approximately $151 million to $157 million.Neues Narrative • Jul 21
Long-Term GLP-1 Tailwinds And New Procedures Will Transform Future Earnings Potential
Catalysts About AirSculpt Technologies AirSculpt Technologies operates centers that provide minimally invasive body contouring, skin tightening and related aesthetic procedures. What are the underlying business or industry changes driving this perspective?Narrative-Update • Jun 26
AIRS: Raised Price View And 2026 Outlook Will Shape Fair Risk Balance
Analysts have raised their price target on AirSculpt Technologies stock from $3.00 to $4.50, citing updated views on fair value, discount rate, revenue growth, profit margin and future P/E assumptions. What’s in the News for AirSculpt Technologies AirSculpt Technologies affirmed revenue guidance for the full year 2026, with expectations of approximately US$151 million to US$157 million.Analyseartikel • Jan 06
AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) Share Price Is Still Matching Investor Opinion Despite 35% Slump
Unfortunately for some shareholders, the AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) share price has dived 35% in the...Seeking Alpha • Oct 29
AirSculpt Technologies: Upgrading To Buy On Improving Fundamentals
Summary Upgrade AirSculpt Technologies (AIRS) to 'Buy' as strong technical momentum and record lead generation drive optimism for further upside. AIRS delivered positive sequential growth in Q2, with improved gross margins, reduced SG&A expenses, and lower customer acquisition costs supporting profitability. Debt reduction and the highest operating cash flow in eight quarters position AIRS closer to sustained profitability, despite macro risks and elevated valuation. Q3 earnings are critical; AIRS must meet or exceed $39.8 million in revenue to maintain momentum and justify its premium sales multiple. Read the full article on Seeking AlphaAnalyseartikel • Oct 05
AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) Shares Climb 32% But Its Business Is Yet to Catch Up
Despite an already strong run, AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares have been powering on, with a gain...Analyseartikel • Sep 24
Estimating The Intrinsic Value Of AirSculpt Technologies, Inc. (NASDAQ:AIRS)
Key Insights AirSculpt Technologies' estimated fair value is US$7.56 based on 2 Stage Free Cash Flow to Equity...Analyseartikel • Aug 29
Here's Why AirSculpt Technologies (NASDAQ:AIRS) Can Afford Some Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...Analyseartikel • Jul 25
AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) 28% Share Price Surge Not Quite Adding Up
Despite an already strong run, AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares have been powering on, with a gain...Analyseartikel • Jun 10
AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) Shares Climb 69% But Its Business Is Yet to Catch Up
The AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) share price has done very well over the last month, posting an...Analyseartikel • Apr 25
Some Confidence Is Lacking In AirSculpt Technologies, Inc. (NASDAQ:AIRS) As Shares Slide 31%
To the annoyance of some shareholders, AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares are down a considerable 31...Analyseartikel • Feb 25
AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) Share Price Matching Investor Opinion
It's not a stretch to say that AirSculpt Technologies, Inc.'s ( NASDAQ:AIRS ) price-to-sales (or "P/S") ratio of 1.4x...Analyseartikel • Jan 28
Investors Could Be Concerned With AirSculpt Technologies' (NASDAQ:AIRS) Returns On Capital
Ignoring the stock price of a company, what are the underlying trends that tell us a business is past the growth phase...Analyseartikel • Dec 04
An Intrinsic Calculation For AirSculpt Technologies, Inc. (NASDAQ:AIRS) Suggests It's 40% Undervalued
Key Insights Using the 2 Stage Free Cash Flow to Equity, AirSculpt Technologies fair value estimate is US$12.46 Current...Analyseartikel • Nov 14
Why Investors Shouldn't Be Surprised By AirSculpt Technologies, Inc.'s (NASDAQ:AIRS) 30% Share Price Surge
Despite an already strong run, AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares have been powering on, with a gain...Analyseartikel • Nov 07
Is AirSculpt Technologies (NASDAQ:AIRS) A Risky Investment?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Analyseartikel • Oct 20
The Return Trends At AirSculpt Technologies (NASDAQ:AIRS) Look Promising
There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Analyseartikel • Sep 28
Optimistic Investors Push AirSculpt Technologies, Inc. (NASDAQ:AIRS) Shares Up 29% But Growth Is Lacking
AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shareholders have had their patience rewarded with a 29% share price jump...Analyseartikel • Sep 25
Is It Time To Consider Buying AirSculpt Technologies, Inc. (NASDAQ:AIRS)?
AirSculpt Technologies, Inc. ( NASDAQ:AIRS ), might not be a large cap stock, but it saw a significant share price rise...Analyseartikel • Aug 01
The Market Lifts AirSculpt Technologies, Inc. (NASDAQ:AIRS) Shares 26% But It Can Do More
Those holding AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares would be relieved that the share price has rebounded...Analyseartikel • Apr 04
There's Been No Shortage Of Growth Recently For AirSculpt Technologies' (NASDAQ:AIRS) Returns On Capital
What are the early trends we should look for to identify a stock that could multiply in value over the long term...Analyseartikel • Feb 23
Here's Why AirSculpt Technologies (NASDAQ:AIRS) Can Manage Its Debt Responsibly
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...Analyseartikel • Dec 14
AirSculpt Technologies, Inc. (NASDAQ:AIRS) Stocks Shoot Up 31% But Its P/S Still Looks Reasonable
AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shareholders are no doubt pleased to see that the share price has bounced...Analyseartikel • Nov 12
US$8.19: That's What Analysts Think AirSculpt Technologies, Inc. (NASDAQ:AIRS) Is Worth After Its Latest Results
There's been a notable change in appetite for AirSculpt Technologies, Inc. ( NASDAQ:AIRS ) shares in the week since its...Analyseartikel • Sep 20
Be Wary Of AirSculpt Technologies (NASDAQ:AIRS) And Its Returns On Capital
When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...Analyseartikel • Oct 29
Capital Allocation Trends At AirSculpt Technologies (NASDAQ:AIRS) Aren't Ideal
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...Seeking Alpha • Aug 27
AirSculpt Technologies: Niche Offering Offset By Profitability, Valuation
Summary AirSculpt Technologies presents with a unique offering with exposure to alternative medical sectors in cosmetics. The company's growth strategy is well received but comes with notable execution risks. Shares appear to be reasonably valued at current levels, however, deeper examination of financials places questions on just what we are buying. With these points in mind, we value AIRS a hold. Investment summary AirSculpt Technologies, Inc. (AIRS) has piqued our interest since listing back in FY21. It operates in a novel segment of 'body contouring procedures' and is best known for its AirSculpt procedure, under the subsidiary brand Elite Body Sculpture. The proprietary procedure is touted due to its minimally invasive nature that contrasts to traditional liposuction. Its growth strategy is to open new centres and expand/relocate existing ones, ultimately driving up revenue per case, cases per room and overall case numbers as part of its growth strategy. Exhibit 1. AIRS 6-month price action Data: Refinitiv Eikon Despite the allure, forensics over its financial statements reveal there to be a loose fit to the kind of equity premia we are seeking exposure to in H2 FY22. Valuations are supportive of a neutral view and regulatory headwinds in adjacent markets [Australia, to be specific] has us cautious on the ramifications for global peers. With these points in mind, we rate AIRS a hold. Q2 earnings indicate growth trends We see the differentiated strengths of AIRS' procedures in its most recent earnings, with upsides to consensus at the top and bottom lines. Forecasts on the global cosmetic market growth published in April 2022 predict a geometric growth of 3.6% per year from 2021 until 2028. Contrary evidence suggests a 9.6% CAGR into 2030. AIRS printed revenue of $49.7 million for the period, up 42% YoY. Presuming either of the above forecasts are true, then AIRS above top-line growth suggest it gained additional market share during the quarter. As a side note, however, this is a murky segment - recent controversies in the Australian cosmetic surgery market surrounding regulation are a potential risk for global participants. Cases also increased 22.5% YoY to 3,691 total cases, as seen in Exhibit 2. The company records each case as 1 visit, with doesn't factor in that each patient may have multiple treatment areas per visit. Nevertheless, it opened 4 new centres during Q2 FY21, bringing total centres to 19. Meanwhile, revenue per case increased 16% YoY to ~$13,450, supported by the company's access to 38 procedure rooms versus 25 the year prior. However, the 10-Q did note that cases per procedure room declined due to the addition of the 13 new centres and expansion of existing ones, versus an organic decline over the 12 months. There is good reason to estimate that trends will normalize as procedures per room level to overall company growth trends. Exhibit 2. Above-market growth statistics imply the company might be gaining additional market share Image: HB Insights, AIRS SEC Filings Despite the upsides in booked revenues for the quarter, our findings indicate there are drains and pulls on liquidity that may place stress on AIRS' current position. As seen below, we estimate there to be around 3-4 quarters of cash runway remaining with the company's most recent earnings. It needs a substantial growth in cash conversion from net income to bolster its position here and prevent additional dilutive equity raise(s) and/or expensive debt issuance/origination in the high yield debt capital markets. Noteworthy to this point, however, is the company declared a $0.41/share special dividend to be paid in September. Exhibit 3. Data: HB Insights Estimates The company also reports non-GAAP EBITDA and recorded a $1.01 million YoY increase to $15.2 million as seen in Exhibit 4. This is despite earnings narrowing by 94% YoY from ~$10 million to $583,000. According to the 10-Q, "management assesses and believes investors should assess our operating performance" [using non-GAAP EBITDA]. We take some issue with this recommendation. Firstly, the company booked ~$7.3 million in stock-based compensation ("SBC") for the period, and saw an interest expense of $1.5 million - each up substantially on the year. Moreover, as seen below, AIRS asks us to ignore the impact of new centre opening and relocation costs, plus the SBC, plus the loss on asset disposals. We argue these are expenses that must be realized in the analysis of free cash flow and valuation. We can't simply ignore that these 3 expenses in particular total to $9.3 million, and removing them from the equation, non-GAAP EBITDA is ~$5.9 million. Not to mention, it also recorded a $60 million payment to its parent organization. Therefore, whilst it converted $8.5 million in quarterly cash flow, this was more than offset by these expenditures. Exhibit 4. Non-GAAP EBITDA includes several expenditures that we argue should be included in cash flow analysis Data: AIRS 10-Q, Q2 FY2022 Valuation AIRS' growth strategy involves opening de novo centres, expanding existing ones and acquiring additional assets into its portfolio. In that regard, AIRS' corporate value stems from its popular set of procedures - particularly AirSculpt liposuction - as an intangible plus its tangible book value. Any value manager will also familiarize this information with cash flow multiples and forecasts.Aktionärsrenditen
| AIRS | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | 4.3% | -1.5% | 0.8% |
| 1Y | -18.7% | 46.6% | 19.1% |
Rendite im Vergleich zur Industrie: AIRS unter dem Niveau der Branche US Healthcare , die im vergangenen Jahr eine Rendite von 46.6% erzielte.
Rendite vs. Markt: AIRS hinter dem Markt US zurück, der im vergangenen Jahr eine Rendite von 19.1 erzielte.
Preisvolatilität
| AIRS volatility | |
|---|---|
| AIRS Average Weekly Movement | 12.3% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.2% |
Stabiler Aktienkurs: Der Aktienkurs von AIRS war in den letzten 3 Monaten im Vergleich zum US -Markt volatil.
Volatilität im Zeitverlauf: AIRSDie wöchentliche Volatilität (12%) war im vergangenen Jahr stabil, liegt aber immer noch höher als bei 75 % der US Aktien.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 2012 | 347 | Yogi Jashnani | www.airsculpt.com |
AirSculpt Technologies, Inc. fungiert zusammen mit seinen Tochtergesellschaften als Holdinggesellschaft für die EBS Intermediate Parent LLC, die in den Vereinigten Staaten und Kanada Dienstleistungen im Bereich der Körperkonturierung anbietet. Das Unternehmen bietet AirSculpt an, eine Körperkonturierungsbehandlung, bei der Fett entfernt und die Haut gestrafft wird, während gleichzeitig gezielte Bereiche des Körpers in einem minimalinvasiven Verfahren geformt werden. Außerdem bietet es AirSculpt+ an, ein Verfahren, mit dem Fett dauerhaft entfernt und die Haut mit beispielloser Präzision und Finesse gestrafft wird, sowie AirSculpt Smooth, ein fortschrittliches Verfahren zur Entfernung von Cellulite.
AirSculpt Technologies, Inc.'s Grundlagenzusammenfassung
| AIRS grundlegende Statistiken | |
|---|---|
| Marktanteil | US$342.15m |
| Gewinn(TTM) | -US$11.22m |
| Umsatz(TTM) | US$151.84m |
2.2x
Kurs-Umsatz-Verhältnis-30.3x
Kurs-Gewinn-Verhältnis Ist AIRS zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| AIRS Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | US$151.84m |
| Kosten der Einnahmen | US$51.53m |
| Bruttogewinn | US$100.31m |
| Sonstige Ausgaben | US$111.53m |
| Gewinn | -US$11.22m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | -0.16 |
| Bruttomarge | 66.06% |
| Nettogewinnspanne | -7.39% |
| Schulden/Eigenkapital-Verhältnis | 44.7% |
Wie hat sich AIRS auf lange Sicht entwickelt?
Historische Performance und VergleicheUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/07/31 03:16 |
| Aktienkurs zum Tagesende | 2026/07/31 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details zum Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite; außerdem bieten wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf Youtube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
AirSculpt Technologies, Inc. wird von 7 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Sam Eiber | BTIG |
| Michael Gorman | BTIG |
| Benjamin Mayo | Leerink Partners LLC |